U.S. market Closed. Opens in 1 hour 30 minutes

CYCN | Cyclerion Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/A297.00K3.32M2.30M4.51MN/AN/AN/A
Cost of RevenueN/A65.00K472.00KN/AN/A1.53M1.75M2.17M
Gross ProfitN/A232.00K2.85M2.30M4.51M-1.53M-1.75M-2.17M
Operating Expenses9.65M44.67M57.63M85.23M129.54M115.25M93.92M61.38M
Selling, General & Admin8.13M14.50M20.62M28.82M34.40M27.54M15.12M10.48M
Research & Development1.51M31.49M37.64M56.41M95.14M87.72M78.80M50.90M
Other Operating ExpensesN/A-1.33M-622.00KN/AN/AN/AN/AN/A
Operating Income-9.65M-44.37M-55.20M-81.27M-125.04M-115.25M-93.92M-63.55M
Other Expenses / Income-2.95M294.00K3.55M3.46M2.03MN/AN/AN/A
Before Tax Income-12.59M-44.08M-51.65M-77.80M-123.01M-115.25M-93.92M-63.55M
Income Tax ExpensesN/A-294.00K16.00K-5.13M-2.03M1.37MN/AN/A
Net Income-21.02M-43.78M-51.66M-72.67M-120.98M-115.25M-93.92M-63.55M
Interest ExpensesN/A294.00K16.00KN/AN/AN/AN/AN/A
Basic Shares Outstanding2.34M2.17M1.96M1.52M1.37M1.37M1.37M1.37M
Diluted Shares Outstanding2.34M2.17M1.96M1.52M1.37M1.37M1.37M1.37M
EBITDA-12.59M-18.18M-55.20M-81.27M-122.34M-113.72M-92.18M-61.38M
EBITDA Margin0.00%-6,121.55%-1,662.50%-3,539.42%-2,714.38%0.00%0.00%0.00%
EBIT-21.02M-43.78M-51.63M-77.80M-123.01M-113.89M-93.92M-63.55M
EBIT Margin0.00%-14,742.09%-1,555.15%-3,388.59%-2,729.27%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙